CD79A and pneumonia: An Italian multicentre prospective cohort study identified specific CVID clinical phenotype characterised by a high pneumonia risk: low IgG and IgA levels at the time of diagnosis, an IgA level < 7 mg/dL, and bronchiectasis [31].